Oncology Institute Inc (TOI)

[glenn1919]

TOI..........................https://stockcharts.com/h-sc/ui?s=TOI&p=W&b=5&g=0&id=p86431144783

[Monksdream]

TOI
New 52 week low

[boston127]

Thanks. I like it.

I may approach them about reselling my company's product.

[TrendTrade2016]

MREO MY FAV BIO

[boston127]

I did. Where do you recommend next?

Is this going to be a better play soon? I am in heavy, and in the red, with LGHL. would appreciate a quick look and feedback on that board, not here. TOI has so many good things going for it - owned by institutions - it is going to be hard for me not to eventually get in here.

[boywonder1]

The chart has contradictions like yourself and you're posting history ‼️‼️2😂

[TrendTrade2016]

Glad you listened

[boston127]

You were correct. Took a major haircut.

Glad I did not jump in. Thanks. What do you like?

[boston127]

The Warrants do not expire

until November, 2026. I may start adding them. I can get 10 Ws for every 1 Common.

[boston127]

What important indicators?

TOI appears to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.
As of 3:00 PM ET Friday, 11/03/2023

[TrendTrade2016]

important indicators going down as stock is going up...red flag!!!!

[boston127]

Can you explain?

Do you know anything about the warrants? Strike price, expiration date, etc.

[TrendTrade2016]

CHART HAS SOME CONTRADICTIONS

[boston127]

It sure is acting perky.

Nice move AH and Premarket. I'm going to jump in today if the move north continues.

[boston127]

Common goes down.

Warrants go up on very light volume. Hard to figure.

[hedge_fun]

She was under 40 cents in mid June……

I would say she’s is already flying.

Been my best play this year.

[TrendTrade2016]

TOI...READY TO FLY

[TrendTrade2016]

TOI...READY TO FLY

[TrendTrade2016]

MONSTER IN DA MAKING

[hedge_fun]

It’s tripled since mid-June…..

[TrendTrade2016]

MONSTER PLAY HERE....

[TrendTrade2016]

TOI BEAUTY BOTTOM HERE ...AI CANCER PLAY

[hedge_fun]

Company repurchasing more shares. Nice…..

[hedge_fun]

August starting out like July…….

[hedge_fun]

On watch. Thx

[CaptPete1776]

Keep eye in $Getr over .55. That’s the breakout spot could explode over .70. I’ve been swinging this also.

[CaptPete1776]

I have some left yes just don’t want to get to greedy

[hedge_fun]

I hope you’re still holding some. I’m enjoying the ride.

[CaptPete1776]

Looks great. I sold some here .89

[hedge_fun]

I don’t want July to end!!!

[CaptPete1776]

Holding in today's nasdaq slide and up on the day. .90 is coming next

[CaptPete1776]

Yes definitely

[hedge_fun]

Been a nice move the past 2 weeks……

[hedge_fun]

The low volume dips with 100 share trades……

are fishy.

Maybe this proves to be support.

Long term hold for me.

[CaptPete1776]

Let’s get more good new out. It’s been holding strong since the last news about stock repurchase plan.

[hedge_fun]

On June 14, 2023, the Board of Directors of The Oncology Institute, Inc. (the “Company”) approved a share repurchase program with authorization to purchase up to 5 million shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). The Company may repurchase shares from time to time through one or more securities broker-dealers, in open market purchases and negotiated purchases, in each case at price per share not to exceed $0.75. Shares repurchased by the Company pursuant to the share repurchase program shall be returned to the status of authorized but unissued shares of Common Stock.

In connection with the foregoing, on June 14, 2023, the Company entered into a limited consent (the “Limited Consent”), dated as of June 14, 2023, to that certain Facility Agreement, dated as of August 9, 2022 (the “Facility Agreement”), by and among the Company, as borrower, certain of the Company’s subsidiaries from time to time party thereto as guarantors and Deerfield Partners, L.P., as agent for itself and the lenders (collectively, “Deerfield”). The Limited Consent permits the repurchase by the Company on or prior to June 16, 2023, of up to 5,000,000 shares of the Company’s Common Stock in one or more open market or negotiated purchases, in each case at price per share not to exceed $0.75. The actual timing and amount of repurchases are subject to business and market conditions, corporate and regulatory requirements, stock price, acquisition opportunities and other factors. The Limited Consent does not obligate the Company to repurchase any amount of shares, and there can be no assurance that any shares will be repurchased. The Limited Consent also grants a one-time waiver under the Facility Agreement of certain delivery of any notice requirements.

The foregoing description of the Limited Consent does not purport to be complete and is qualified in its entirety by reference to the full text of the Limited Consent, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.